tirozinkinázgátlókat
Tirozinkinázgátlók, or tyrosine kinase inhibitors (TKIs), are a class of drugs used in cancer therapy. They work by targeting specific proteins called tyrosine kinases, which are often overactive in cancer cells and promote their growth and division. By blocking the action of these kinases, TKIs can slow down or stop cancer progression.
These drugs are a significant advancement in targeted therapy. Instead of broadly affecting all rapidly dividing
TKIs are typically administered orally, often as pills. Their development has been a result of extensive research
While TKIs have revolutionized cancer treatment for many, they are not universally effective. Their success depends